U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 08:31:49 GMT 2023
Edited
by admin
on Sat Dec 16 08:31:49 GMT 2023
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
DLE8519RWM
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
ENFORTUMAB VEDOTIN
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Common Name English
ENFORTUMAB VEDOTIN [MI]
Common Name English
ENFORTUMAB VEDOTIN [JAN]
Common Name English
Enfortumab vedotin [WHO-DD]
Common Name English
enfortumab vedotin [INN]
Common Name English
ENFORTUMAB VEDOTIN [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1512
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
NCI_THESAURUS C129823
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
Code System Code Type Description
DRUG CENTRAL
5366
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
RXCUI
2277607
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
ALTERNATIVE
ChEMBL
CHEMBL3301589
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
INN
9821
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
MERCK INDEX
m12189
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
FDA UNII
DLE8519RWM
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
DAILYMED
DLE8519RWM
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
DRUG BANK
DB13007
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
CAS
1346452-25-2
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
RXCUI
2268306
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
USAN
BC-32
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
NCI_THESAURUS
C114500
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
WIKIPEDIA
Enfortumab vedotin
Created by admin on Sat Dec 16 08:31:49 GMT 2023 , Edited by admin on Sat Dec 16 08:31:49 GMT 2023
PRIMARY
From To
1_22 1_96
1_144 1_200
1_261 1_321
1_367 1_425
2_22 2_96
2_144 2_200
2_261 2_321
2_367 2_425
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_220 3_214
2_220 4_214
1_226 2_226
1_229 2_229
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_297
N 2_297
Related Record Type Details
DERIVATIVE -> PARENT
CONJUGATE COMPONENT->CONJUGATE
SUB_CONCEPT->SUBSTANCE
CONJUGATE COMPONENT->CONJUGATE
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:ESTIMATED(CALCULATED) CHEMICAL